AI-generated summary
The authors compared non-ablative 1,550 nm fractional laser therapy with triple topical therapy in a split-face randomized study of 29 patients with melasma. They report that the laser side showed worse hyperpigmentation on physician and instrument measures and lower patient satisfaction, with 31% developing postinflammatory hyperpigmentation, while the topical side showed no significant change.
- Participants
- 29
- Who or what was studied
- Patients with melasma
- Limits stated in the abstract
- The abstract reports a small sample of 29 patients and does not describe the blinding or follow-up limits beyond 6 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 550 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.